Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Otolaryngology (Ear, Nose, Throat) | Family Medicine

Head and Neck Cancer Clinical Trials

A listing of Head and Neck Cancer medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 3 Last 

Alabama

University of Alabama at Birmingham
Birmingham Alabama 35233

A clinical trial seeking patients for a research study for the treatment of Head and Neck Cancer or Advanced Solid Tumors

Arizona

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating BIND-014 for the treatment of Metastatic Cancer, Cancer or Solid Tumors

Scottsdale Arizona

Patients are needed to participate in a clinical research study evaluating Ferumoxytol followed by MM-398

Scottsdale Arizona 85258
Updated

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

California

Greenbrae California 94904

Patients are needed to participate in a clinical research study evaluating BIND-014 for the treatment of Metastatic Cancer, Cancer or Solid Tumors

Moores UC San Diego Cancer Center
La Jolla California 92037

A clinical trial to evaluate treatments using GL-ONC1 for patients with Cancer of Head and Neck

University of Southern California
Los Angeles California 90033

A clinical study for patients with Cystic Fibrosis

Los Angeles California 90048

Patients are needed to participate in a clinical research study evaluating BIND-014 for the treatment of Metastatic Cancer, Cancer or Solid Tumors

Los Angeles California 90025
Updated

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

View More »

University of California, San Francisco
San Francisco California 94115

A Phase 2 clinical study for patients with Locally Advanced Basal Cell Carcinoma, Skin Cancer or Cutaneous Malignancy

Stanford University School of Medicine
Stanford California 94305

A clinical study for patients with Head and Neck Cancer

Stanford California 94305
Updated

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Colorado

University of Colorado School of Medicine
Aurora Colorado 80045

Patients are needed to participate in a clinical research study evaluating rigosertib

Aurora Colorado 80045
Updated

Patients are needed to participate in a clinical research study for the treatment of Head and Neck Cancer

Denver VA Medical Center-ECHCS
Denver Colorado 80220

Patients are needed to participate in a clinical research study evaluating rigosertib

Connecticut

New Haven Connecticut 06510-3221
Updated

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

District of Columbia

Georgetown Lombardi Comprehensive Cancer Center
Washington District of Columbia 20007

A clinical research study of Nilotinib + Cetuximab for the treatment of Colorectal Cancer or Head and Neck Cancer

Florida

Fort Myers Florida 33905

Patients are needed to participate in a clinical research study evaluating BIND-014 for the treatment of Metastatic Cancer, Cancer or Solid Tumors

Tampa Florida 33612-9497
Updated

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Georgia

Memorial University Medical Center
Savannah Georgia 31404

ECOG E1305: A Phase III Randomized Trial of Chemotherapy with or without Bevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer.

Memorial University Medical Center
Savannah Georgia 31404

RTOG 0920: A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer.

Memorial University Medical Center
Savannah Georgia 31404

RTOG 1016. Phase III Trial of Radiotherapy plus Cetuximab versus Chemoradiotherapy in HPV-Associated Oropharynx Cancer.

Illinois

Sherman Health
Elgin Illinois 60123

ECOG E1305 A Phase III Randomized Trial of Chemotherapy with or without Bevacizumab In Patients with Recurrent Or Metastatic Head and Neck Cancer

Sherman Health
Elgin Illinois 60123

RETAIN: Resistance Training and Physical Functioning in Patients with Head & Neck Cancer

View More »

The University of Chicago Medical Center
Chicago Illinois 60637

A clinical research study of Everolimus escalating dose and Everolimus or Placebo for the treatment of Head and Neck Cancer

The University of Chicago Medical Center
Chicago Illinois 60637

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Northwestern University
Chicago Illinois 60611

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

University of Illinois-Chicago
Chicago Illinois 60612

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Ingalls Cancer Research Center
Harvey Illinois 60426

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Kansas

University of Kansas
Kansas City Kansas 66160

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Louisiana

Louisianna State University
Shreveport Louisiana 71130

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Maryland

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital
Baltimore Maryland 21287

A clinical trial to evaluate treatments using pNGVL-4a-CRT/E7 (detox) DNA vaccine for patients with HPV-related Head and Neck Cancer

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Baltimore Maryland 21231

A Phase 1/Phase 2 clinical study for patients with Head and Neck Cancer

Baltimore Maryland 21231
Updated

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Massachusetts

Tufts Medical Center
Boston Massachusetts 02111

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Dana-Farber Cancer Institute
Boston Massachusetts 02215

A Prospective Observational Study to Evaluate Acute Kidney Injury Biomarkers In Patients Receiving First Cycle of Cisplatin Chemotherapy for Head and Neck Cancers

Boston Massachusetts 02114
Updated

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Boston Massachusetts 02215
Updated

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Michigan

University of Michigan
Ann Arbor Michigan 48109

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Detroit Michigan 48201

Patients are needed to participate in a clinical research study evaluating BIND-014 for the treatment of Metastatic Cancer, Cancer or Solid Tumors

Minnesota

University of Minnesota - Cystic Fibrosis Center
Minneapolis Minnesota 55455

A clinical study for patients with Cystic Fibrosis

University of Minnesota
Minneapolis Minnesota 55455

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Mississippi

View More »

University of Mississippi
Jackson Mississippi 39216

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Missouri

St. Joseph Missouri 64507

Patients are needed to participate in a clinical research study of MEHD7945A and cetuximab to evaluate Head and Neck Cancer

Washington University
St. Louis Missouri 63110

A clinical trial to evaluate treatments using Everolimus (RAD 001) or placebo for patients with Head and Neck Cancer

Nevada

Las Vegas Nevada 89169
Updated

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

First 1 2 3 Last